Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis

被引:9
作者
Xu, Tai [1 ,2 ]
Zhang, Siming [1 ]
Qiu, Dongqin [1 ]
Li, Xiaoyuan [1 ]
Fan, Yuanlin [1 ]
机构
[1] Meizhou Peoples Hosp, Dept Breast Surg, 63 Huangtang Rd, Meizhou 514000, Guangdong, Peoples R China
[2] Meizhou Peoples Hosp, Guangdong Prov Key Lab Precis Med & Clin Translat, Meizhou 514000, Guangdong, Peoples R China
关键词
Breast cancer; Matrix metalloproteinase 9; Polymorphism; Meta-analysis; MATRIX METALLOPROTEINASES; GENETIC POLYMORPHISMS; PROMOTER REGIONS; GELATINASE-B; MMP-9; STATISTICS; EXPRESSION; SUSCEPTIBILITY; PROGRESSION; SURVIVAL;
D O I
10.1016/j.gene.2020.144972
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Numerous studies have sought associations between matrix metalloproteinase 9 (MMP-9) polymorphisms and breast cancer risk. However, these studies have yielded conflicting results. Hence, we performed an updated meta-analysis to clarify the effects of four MMP-9 gene polymorphisms (rs3918242, rs2250889, rs3787268, and rs17576) on breast cancer risk. Methods: A comprehensive literature search for eligible studies was conducted in five electronic databases, including PubMed, Embase and Web of Science, up to March 1, 2020. Summary odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of associations in random-effects models. For the reduction of type I errors, a trial sequential analysis (TSA) was performed. Results: Twenty-one studies (8813 breast cancer cases and 9323 controls) were included in the quantitative analysis. For rs3918242, the overall ORs were significant under allelic comparison (OR (A vs. G) = 1.34; 95% CI 1.03, 1.74, P = 0.028) and the recessive genetic model (OR (AA vs. GG+GA) = 1.40; 95% CI 1.06, 1.84, P = 0.016). For rs2250889, the ORs were significant under homozygote comparison (OR (GG vs. CC) = 2.57; 95% CI 1.22, 5.42, P = 0.013), heterozygote comparison (OR (GC vs. CC) = 2.48; 95% CI 1.17, 5.23, P = 0.018), and the dominant genetic model (OR (GG+GC vs. CC) = 2.53; 95% CI 1.23, 5.20, P = 0.012). No associations were observed for rs3787268 or rs17576. The subgroup analyses indicated that the risk effect of the rs3918242 A allele was observed only among Asians. TSA showed that the findings for rs3918242, rs3787268, and rs17576 were robust, but many more patients are needed before definitive conclusions can be made for rs2250889. Conclusion: Our meta-analysis suggests that MMP-9 rs3918242, but not rs3787268 and rs17576 polymorphisms, may be risk factors for breast cancer. The effect of rs2250889 needs further confirmation with a larger sample size.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Association Between Three eNOS Polymorphisms and Cancer Risk: a Meta-analysis
    Wu, Xun
    Wang, Zhi-Feng
    Xu, Yin
    Ren, Rui
    Heng, Bao-Li
    Su, Ze-Xuan
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (13) : 5317 - 5324
  • [42] Association between EGF promoter polymorphisms and cancer risk: a meta-analysis
    Xu, Wei
    Li, Yan
    Wang, Xueli
    Chen, Bo
    Liu, Shan
    Wang, Yan
    Zhao, Weihong
    Wu, Jianqing
    [J]. MEDICAL ONCOLOGY, 2010, 27 (04) : 1389 - 1397
  • [43] Association between EGF promoter polymorphisms and cancer risk: a meta-analysis
    Wei Xu
    Yan Li
    Xueli Wang
    Bo Chen
    Shan Liu
    Yan Wang
    Weihong Zhao
    Jianqing Wu
    [J]. Medical Oncology, 2010, 27 : 1389 - 1397
  • [44] Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis
    Jiang, Zheng
    Li, Chunxiang
    Xu, Ye
    Cai, Sanjun
    Wang, Xishan
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (01) : 203 - 212
  • [45] Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis
    Lu, Pei-Hua
    Wei, Mu-Xin
    Yang, Jie
    Liu, Xiao
    Tao, Guo-Qing
    Shen, Wei
    Chen, Min-Bin
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (02) : 537 - 543
  • [46] Exploring association between statin use and breast cancer risk: an updated meta-analysis
    Islam, Md. Mohaimenul
    Yang, Hsuan-Chia
    Phung-Anh Nguyen
    Poly, Tahmina Nasrin
    Huang, Chih-Wei
    Kekade, Shwetambara
    Khalfan, Abdulwahed Mohammed
    Debnath, Tonmoy
    Li, Yu-Chuan Jack
    Abdul, Shabbir Syed
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2017, 296 (06) : 1043 - 1053
  • [47] Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis
    Wang, Jiying
    Cai, Yong
    [J]. TUMOR BIOLOGY, 2012, 33 (06) : 1819 - 1828
  • [48] Exploring association between statin use and breast cancer risk: an updated meta-analysis
    Md. Mohaimenul Islam
    Hsuan-Chia Yang
    Phung-Anh Nguyen
    Tahmina Nasrin Poly
    Chih-Wei Huang
    Shwetambara Kekade
    Abdulwahed Mohammed Khalfan
    Tonmoy Debnath
    Yu-Chuan Jack Li
    Shabbir Syed Abdul
    [J]. Archives of Gynecology and Obstetrics, 2017, 296 : 1043 - 1053
  • [49] Association between GSTM1 polymorphisms and lung cancer: an updated meta-analysis
    Liu, H.
    Ma, H. F.
    Chen, Y. K.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 1385 - 1392
  • [50] The association between HOTAIR polymorphisms and cancer susceptibility: An updated systematic review and meta-analysis
    Min, Ling
    Mu, Xiyan
    Tong, An
    Qian, Yanping
    Ling, Chen
    Yi, Tao
    Zhao, Xia
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S33 - S33